Evidence map›Paper›PMID 42894548›Full record

ArticleF1000Research2026

Isolation of

Aarushi Venkatakrishnan, Chelsea Swanson, Antara Palkar, David Takamiya, Joshua T Sarafian, Jennifer Mauney, Margaret W Gatongi, Jasmine Cendejas Hernandez, Victoria Lawton, Zoie E Holzknecht and 6 more

Abstract read
In one paragraph

Article in F1000Research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Aarushi VenkatakrishnanSurgery, Duke University Medical Center, Durham, NC, 27710, USA.
Chelsea SwansonSurgery, Duke University Medical Center, Durham, NC, 27710, USA.
Antara PalkarSurgery, Duke University Medical Center, Durham, NC, 27710, USA.
David TakamiyaSurgery, Duke University Medical Center, Durham, NC, 27710, USA.
Joshua T SarafianSurgery, Duke University Medical Center, Durham, NC, 27710, USA.
Jennifer MauneyWPLab, Durham, NC, 27705, USA.
Margaret W GatongiDuke Pratt School of Engineering, Durham, NC, USA.
Jasmine Cendejas HernandezSurgery, Duke University Medical Center, Durham, NC, 27710, USA.
Victoria LawtonSurgery, Duke University Medical Center, Durham, NC, 27710, USA.
Zoie E HolzknechtSurgery, Duke University Medical Center, Durham, NC, 27710, USA.ORCID https://orcid.org/0009-0000-6012-162X
John P Jones IiiWPLab, Durham, NC, 27705, USA.
Zacharoula KonsoulaWPLab, Durham, NC, 27705, USA.
Kateřina JirkůInstitute of Parasitology, Czech Academy of Sciences, Branišovská, Czech Republic.
Garin AgliettiWPLab, Durham, NC, 27705, USA.
Detlev GojTanawisa Company Ltd, Pranakornsriayuthaya, Thailand.
William ParkerSurgery, Duke University Medical Center, Durham, NC, 27710, USA.ORCID https://orcid.org/0000-0003-3644-9152

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Helminth therapy holds considerable theoretical promise for clinical and public health applications. Unfortunately, clinical trials have often used helminths produced using methods that are both highly variable and insufficiently described in the literature, which may hinder reproducibility and troubleshooting. This study aimed to devise a method for purification of helminths that avoids mechanical filtration, which may damage some organisms. In particular, the goal was to devise a method to separate large quantities of cysticercoids of the cestode species Methods: The physical size and behavior of HDCs in solution were assessed and used to create a patented washing device. Results: The cross-sectional area of HDCs varied over a 10-fold range, from approximately 0.06 to 0.6 mm Conclusions: This study describes a detailed method of purification of HDCs, organisms that could potentially be used for helminth therapy. It is hoped that government agencies or non-profit organizations can use such technology to conduct rigorous clinical trials, potentially leading to the production of reasonably priced therapeutics.

Indexed as

CysticercusHymenolepis diminutaAnimalsallergicautoimmunecestodehelminth therapypurification

Identifiers

PMID42894548
PMCPMC13675623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.